Abstract: Disclosed are catalyst compositions having an internal electron donor which includes a 3,6-di-substituted-1,2-phenylene aromatic diester. Ziegler-Natta catalyst compositions containing the present catalyst compositions exhibit very high hydrogen response, high activity, high selectivity and produce propylene-based olefins with high melt flow rate.

Abstract: A composition is provided which comprises a propylene ethylene random copolymer having a melt flow rate (MFR) (as determined according to ASTM D1238, 230° C., 2.16 Kg) of less than 1 g/10 min, a xylene solubles content of less than 7% by weight, an ethylene content of from 3 to 5 percent by weight of the copolymer, and a value equal to or greater than 92 for the product of the Koenig B value times the % mm triads measured on the xylene insoluble fraction of the random copolymer obtained by the wet method. Pipes made from the composition demonstrate improved pressure endurance.

Abstract: A process for preparing a peptized alumina having increased solids and acid contents and a decreased water content. The process comprising mixing a boehmite or pseudoboehmite alumina and acid with a high intensity, high energy mixer at a ratio of 0.16 to 0.65 moles acid/moles alumina for a time period sufficient to form a substantially free-flowing solid particulate having a solids content of 45 to 65 wt %. When used in catalyst manufacture, peptized alumina produced by the process provides an increased rate in catalyst production and decreased costs due to high solids concentration and the presence of less water to be evaporated.

Abstract: The present disclosure provides a Ziegler-Natta catalyst composition comprising a procatalyst, a cocatalyst and a mixed external electron donor comprising a first selectivity control agent, a second selectivity control agent and an activity limiting agent. A polymerization process incorporating the present catalyst composition produces a high-stiffness propylene-based polymer with a melt flow rate greater than about 50 g/10 min. The polymerization process occurs in a single reactor, utilizing standard hydrogen concentration with no visbreaking.

Abstract: Provided are crystalline forms of nicotinamide riboside, including a Form I of nicotinamide riboside chloride according to formula (I). Also disclosed are pharmaceutical compositions comprising the crystalline Form I of nicotinamide riboside chloride, and methods of producing such pharmaceutical compositions. In other aspects, the present disclosure pertains to methods comprising administering to a subject the crystalline Form I of nicotinamide riboside chloride. The present disclosure also provides methods of preparing the crystalline Form I of nicotinamide riboside chloride. Also provided are a crystalline Form I of nicotinamide riboside chloride that is prepared according to any of the disclosed methods for preparing the crystalline Form I.

Abstract: Solid catalyst components for use in olefin polymerization, olefin polymerization catalyst systems containing the solid catalyst components, methods of making the solid catalyst components and the catalyst systems, and methods of polymerizing and copolymerizing olefins involving the use of the catalyst systems. The solid catalyst components are formed by (a) dissolving a magnesium compound and an auxiliary intermediate electron donor in at least one first solvent to form a solution; (b) contacting a first titanium compound with said solution to form a precipitate of the magnesium compound and the first titanium compound; (c) washing the precipitate with a mixture of a second titanium compound and at least one second solvent and optionally an electron donor at a temperature of up to 90° C.; and (d) treating the precipitate with a mixture of a third titanium compound and at least one third solvent at 90-150° C. to form a solid catalyst component.

Abstract: A process for increasing the overall yield of pyridine or its alkyl pyridine derivatives during a base synthesis reaction is disclosed. The process comprises reacting a C2 to C5 aldehyde, a C3 to C5 ketone or a combination thereof, with ammonia and, optionally, formaldehyde, in the gas phase and in the presence of an effective amount of a particulate catalyst comprising a zeolite, zinc, a binder, and clay and optionally a matrix, wherein the catalyst has a L/B ratio of about 1.5 to about 4.0. Preferably, the zeolite is ZSM-5. A process for enhancing the catalytic activity of a zinc and zeolite containing catalyst to increase the overall yield of pyridine and/or its derivatives during a base synthesis reaction is also disclosed.

Abstract: This invention provides activator precursor compositions and activator compositions. The activator precursor compositions are formed from a support material, a linking compound, and polyfunctional compounds having at least two aromatic groups in which at least two of said aromatic groups each has at least one polar moiety thereon. The activator compositions are formed from a support material, a linking compound, an aluminoxane, and a polyfunctional compound having at least two aromatic groups in which at least two of said aromatic groups each has at least one polar moiety thereon. Also provided are catalyst compositions, processes for forming catalyst compositions, and polymerization processes utilizing the catalyst compositions of this invention.

Abstract: The present disclosure provides a Ziegler-Natta catalyst composition comprising a procatalyst, a cocatalyst and a mixed external electron donor comprising a first selectivity control agent, a second selectivity control agent, and an activity limiting agent. A polymerization process incorporating the present catalyst composition produces a high-stiffness propylene-based polymer with a melt flow rate greater than about 50 g/10 min. The polymerization process occurs in a single reactor, utilizing standard hydrogen concentration with no visbreaking.

Abstract: Provided are crystalline forms of nicotinamide riboside, including a Form II of nicotinamide riboside chloride: nicotinamide riboside chloride. Also disclosed are pharmaceutical compositions comprising the crystalline Form II of nicotinamide riboside chloride, and methods of producing such pharmaceutical compositions. In other aspects, the present disclosure pertains to methods comprising administering to a subject the crystalline Form II of nicotinamide riboside chloride. The present disclosure also provides methods of preparing the crystalline Form II of nicotinamide riboside chloride. Also provided are a crystalline Form II of nicotinamide riboside chloride that is prepared according to any of the disclosed methods for preparing the crystalline Form II.

Abstract: A method for deoxygenating renewable oils comprised of natural oils or greases or derivatives thereof containing triglycerides or free fatty acids includes the steps of: providing a catalyst comprising a support predominantly comprised of alumina with metal compounds provided on the support based on Mo and at least one selected from the group consisting of Ni and Co, and at least one selected from the group consisting of Cu and Cr, and contacting the renewable oils with the catalyst under conditions sufficient to deoxygenate the renewable oils.

Abstract: The presently disclosed and claimed inventive concept(s) relates to solid catalyst components comprising titanium, magnesium, halogen and an internal electron donor compound having at least one ester group and at least one alkoxy group, and catalyst systems containing the catalyst solid components, organoaluminum compounds, and organosilicon compounds. The presently disclosed and claimed inventive concept(s) further relates to methods of making the catalyst components and the catalyst systems, and methods of polymerizing or copolymerizing alpha-olefins using the catalyst systems.

Abstract: A process for increasing the overall yield of pyridine or its alkyl pyridine derivatives during a base synthesis reaction is disclosed. The process comprises reacting a C2 to C5 aldehyde, a C3 to C5 ketone or a combination thereof, with ammonia and, optionally, formaldehyde, in the gas phase and in the presence of an effective amount of a particulate catalyst comprising a zeolite, zinc, a binder, and clay and optionally a matrix, wherein the catalyst has a L/B ratio of about 1.5 to about 4.0. Preferably, the zeolite is ZSM-5. A process for enhancing the catalytic activity of a zinc and zeolite containing catalyst to increase the overall yield of pyridine and/or its derivatives during a base synthesis reaction is also disclosed.

Abstract: Disclosed are silica bound zeolite adsorbent particles which possess high volumetric gas adsorption capacity for the adsorption and/or desorption of gases. The adsorbent are highly effective as a gas source in volumetrically constrained applications. The silica-bound zeolite adsorbents possess a relatively high zeolite content simultaneously with a relatively low intra-particle pore volume as compared to the clay bound zeolite aggregates heretofore used as a gas source in volumetrically constrained environments, e.g. instant beverage carbonation processes, devices or systems.

Abstract: Particles of a procatalyst composition having a particle size D50 from 19 microns to 30 microns. A polymerization process comprising halogenating, in the presence of a substituted phenylene aromatic diester, particles of a MagTi procatalyst precursor to form particles of a procatalyst composition having a particle size D50 from 19 microns to 30 microns; first contacting a propylene and optionally one or more first comonomers with a catalyst composition comprising the particles of the procatalyst composition in a first polymerization reactor to form an active propylene-based polymer; and second contacting the active propylene-based polymer with at least one second comonomer in a second polymerization reactor to form a propylene impact copolymer.

Abstract: A gas-phase process for making a propylene-based polymer in a fluidized-bed reactor, the reactor containing a fluidized bed including polymer product particles and a catalyst, the process having a set of quantitative criteria for maximum monomer partial pressure, maximum reactor temperature, and comonomer content(s) in the propylene-based polymer. The propylene-based polymer may be EBPT or BPRCP. The catalyst may include a catalyst/donor system comprising (1) a supported Ziegler-Natta pro-catalyst, (2) a co-catalyst, and (3) a mixed external electron donor system including (a) an activity limiting agent including at least one carboxylate ester functional group, and (b) a selectivity control agent.

Abstract: A process for the laboratory deactivation of a porous solid comprising subjecting the porous solid to a cyclic treatment, the treatment being selected from a hydration/dehydration cyclic treatment, a thermal cyclic treatment, or combinations thereof.

Abstract: Particles of a procatalyst composition having a particle size D50 from 19 microns to 30 microns. A polymerization process comprising halogenating, in the presence of a substituted phenylene aromatic diester, particles of a MagTi procatalyst precursor to form particles of a procatalyst composition having a particle size D50 from 19 microns to 30 microns; first contacting a propylene and optionally one or more first comonomers with a catalyst composition comprising the particles of the procatalyst composition in a first polymerization reactor to form an active propylene-based polymer; and second contacting the active propylene-based polymer with at least one second comonomer in a second polymerization reactor to form a propylene impact copolymer.

Abstract: Particulate catalytic cracking catalysts which comprise a zeolite having catalytic cracking ability under catalytic cracking conditions, added silica, a magnesium salt, an alumina containing binder, clay and optionally, a matrix material. The catalytic cracking catalyst has a high matrix surface area and is useful in a catalytic cracking process, in particularly, a fluid catalytic cracking process, to provide increased catalytic activity and improved coke and hydrogen selectivity without the need to incorporate rare earth metals.

Abstract: Adsorbent clarification agents suitable for use in bioprocessing procedures are disclosed. Methods of making and using the adsorbent clarification agents are also disclosed.